| Hang Seng Index | 25.980 HKD | +0.360 | +1.405% | 415.24M | 10.75B | 25.639 (+1.329%) HKD as at 2025/09/04 | | |
| Hang Seng China Enterprises | 92.840 HKD | +1.240 | +1.354% | 105.82M | 9.78B | 91.592 (+1.363%) HKD as at 2025/09/04 | | |
| Hang Seng TECH Index | 5.575 HKD | +0.090 | +1.641% | 1.14B | 6.31B | 5.479 (+1.758%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.730 HKD | +0.185 | +3.336% | 197.44M | 1.12B | 5.542 (+3.398%) HKD as at 2025/09/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.454 HKD | -0.054 | -3.581% | 408.04M | 600.85M | 1.512 (-3.849%) HKD as at 2025/09/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.930 HKD | -0.062 | -3.112% | 139.98M | 273.64M | 1.998 (-3.418%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.875 HKD | +0.175 | +3.070% | 40.35M | 234.34M | 5.691 (+3.231%) HKD as at 2025/09/04 | | |
| Hang Seng TECH Index | 11.980 HKD | +0.210 | +1.784% | 14.35M | 171.28M | 11.759 (+1.878%) HKD as at 2025/09/04 | | |
| Hang Seng TECH Index | 5.670 HKD | +0.100 | +1.795% | 30.42M | 171.12M | 5.564 (+1.900%) HKD as at 2025/09/04 | | |
| CSI 300 | 50.380 HKD | +1.320 | +2.691% | 2.85M | 142.86M | 49.340 (+2.109%) HKD as at 2025/09/04 | | |
| FTSE China A50 | 15.800 HKD | +0.270 | +1.739% | 8.33M | 131.30M | 15.629 (+1.092%) HKD as at 2025/09/04 | | |
| Hang Seng China Enterprises | 10.660 HKD | +0.080 | +0.756% | 7.29M | 77.52M | 10.560 (+0.946%) HKD as at 2025/09/04 | | |
| FTSE China A50 | 14.730 HKD | +0.270 | +1.867% | 4.87M | 71.44M | 14.549 (+1.241%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 6.930 HKD | +0.870 | +14.356% | 9.56M | 62.60M | 6.148 (+12.718%) HKD as at 2025/09/04 | | |
| London Gold Fixing Price | 2,551.000 HKD | +6.000 | +0.236% | 21.63K | 55.21M | N/A | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.550 HKD | +0.120 | +1.151% | 2.42M | 25.03M | 10.409 (+1.358%) HKD as at 2025/09/04 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 18.140 HKD | +0.890 | +5.159% | 1.40M | 25.01M | 17.352 (+4.539%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.604 HKD | +0.238 | +5.451% | 5.14M | 23.26M | 4.446 (+3.565%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 18.900 HKD | +0.070 | +0.372% | 1.19M | 22.61M | 18.901 (-0.007%) HKD as at 2025/09/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.688 HKD | -0.084 | -2.227% | 5.64M | 20.83M | 3.714 (-0.705%) HKD as at 2025/09/04 | | |
| SSE Science and Technology Innovation Board 50 Index | 11.700 HKD | +0.440 | +3.908% | 1.81M | 20.77M | 11.319 (+3.371%) HKD as at 2025/09/04 | | |
| FTSE US Treasury 20+ Years Index | 68.320 HKD | +0.460 | +0.678% | 266.35K | 18.21M | 68.205 (+0.168%) HKD as at 2025/09/04 | | |
| CME Ether Futures | 20.620 HKD | +0.240 | +1.178% | 712.86K | 14.40M | 19.901 (+3.615%) HKD as at 2025/09/04 | | |
| Hang Seng High Dividend Yield | 30.100 HKD | +0.580 | +1.965% | 478.17K | 14.26M | 29.574 (+1.779%) HKD as at 2025/09/04 | | |
| ChiNext Index | 11.330 HKD | +0.740 | +6.988% | 1.15M | 12.81M | 10.635 (+6.537%) HKD as at 2025/09/04 | | |
| HSI ESG Enhanced Index (net total return index) | 54.640 HKD | +0.660 | +1.223% | 225.09K | 12.24M | 54.000 (+1.186%) HKD as at 2025/09/04 | | |
| MSCI China | 27.180 HKD | +0.520 | +1.950% | 431.28K | 11.64M | 26.673 (+1.902%) HKD as at 2025/09/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.538 HKD | +0.100 | +2.909% | 3.28M | 11.50M | 3.434 (+3.023%) HKD as at 2025/09/04 | | |
| FactSet China Semiconductor Index (net total return) | 51.900 HKD | +1.900 | +3.800% | 208.21K | 10.56M | 49.895 (+4.018%) HKD as at 2025/09/04 | | |
| London Gold Fixing Price | 83.580 HKD | +0.320 | +0.384% | 112.45K | 9.41M | 83.332 (+0.298%) HKD as at 2025/09/04 | | |